Esr1 Mutant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Esr1 Mutant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Esr1 Mutant Today - Breaking & Trending Today

Dr Jhaveri on the Rationale for the ELAINE-3 Trial in ESR1-Mutant ER+/HER2– Breast Cancer

Published: December 21, 2023

Komal Jhaveri, MD, FACP, discusses the rationale for investigating lasofoxifene alongside abemaciclib in ESR1-mutated estrogen receptor–positive, HER2-negative metastatic breast cancer.

Source: onclive.com

Related Topics:

James CayneKomal JhaveriMemorial Sloan Kettering Cancer CenterEarly Drug Development ServiceEndocrine Therapy Research ProgramJames Cayne ChairJunior FacultyElaine 3Elaine 1Elaine 2Esr1 MutantEr Her2 Negative Breast Cancer